Effectiveness of phosphate binders on mortality and cardiovascular disease in end-stage renal disease patients with hyperphosphatemia: a multicenter real-world cohort study.

BMC Nephrol · 2025 · PMC11895186 · PMID 40065267

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Previous evidence from network meta-analyses (NMA) of randomized controlled trials (RCT) [ 19 , 20 ] of chronic kidney disease (CKD) patients has shown increases in all-cause mortality (between 76% and 89%) in those treated with CBPBs compared to those treated with NCBPBs and sevelamer, although this did not reach statistical significance with lanthanum.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.